Stat5 expression is required for IgE-mediated mast cell function

被引:54
作者
Barnstein, Brian O.
Li, Geqiang
Wang, Zhengqi
Kennedy, Sarah
Chalfant, Charles
Nakajima, Hiroshi
Bunting, Kevin D.
Ryan, John J.
机构
[1] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA
[2] Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA
[3] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA
[4] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chiba, Japan
关键词
D O I
10.4049/jimmunol.177.5.3421
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mast cell (MC) inflammatory response is now linked not only to atopy, but also to arthritis, multiple sclerosis, heart disease, and resistance to bacterial infection. In the current study, we demonstrate that the signal transducer and activator of transcription 5 (Stat5) is rapidly activated by IgE cross-linkage, and that its expression is critical to the MC response. Stat5-deficient (Stat5KO) MC demonstrated a significant decrease in IgE-mediated degranulation, leukotriene B, production, cytokine secretion, and survival signals. The defect in cytokine production may be caused by decreased cytokine mRNA stability. Stat5KO MC-induced cytokine mRNAs normally following IgE cross-linkage, but these mRNAs were not sustained over time and were degraded at twice the rate observed in WT cells. Interestingly, the RNA destabilizing protein tristetraprolin was induced following IgE cross-linkage in Stat5KO but not wild-type cells. Moreover, reducing tristetraprolin expression via short hairpin RNA transfection significantly increased IL-13 production in Stat5KO MC. Our work demonstrates that Stat5 is a critical factor in IgE-induced MC activation, acting in part via posttranscriptional control of cytokine mRNA stability. These data have a direct impact on MC-associated inflammatory and autoimmune diseases.
引用
收藏
页码:3421 / 3426
页数:6
相关论文
共 34 条
[1]  
BAUMGARTNER RA, 1994, J IMMUNOL, V153, P2609
[2]   C-KIT LIGAND - A UNIQUE POTENTIATOR OF MEDIATOR RELEASE BY HUMAN LUNG MAST-CELLS [J].
BISCHOFF, SC ;
DAHINDEN, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :237-244
[3]   STAT protein recruitment and activation in c-Kit deletion mutants [J].
Brizzi, MF ;
Dentelli, P ;
Rosso, A ;
Yarden, Y ;
Pegoraro, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :16965-16972
[4]   Post-transcriptional regulation of pro-inflammatory gene expression [J].
Clark, A .
ARTHRITIS RESEARCH, 2000, 2 (03) :172-174
[5]   Critical protective role of mast cells in a model of acute septic peritonitis [J].
Echtenacher, B ;
Mannel, DN ;
Hultner, L .
NATURE, 1996, 381 (6577) :75-77
[6]   Differential release of mast cell interleukin-6 via c-kit [J].
Gagari, E ;
Tsai, M ;
Lantz, CS ;
Fox, LG ;
Galli, SJ .
BLOOD, 1997, 89 (08) :2654-2663
[7]   Mast cells and basophils [J].
Galli, SJ .
CURRENT OPINION IN HEMATOLOGY, 2000, 7 (01) :32-39
[8]   TGF-β1 inhibits mast cell FcεRI expression [J].
Gomez, G ;
Ramirez, CD ;
Rivera, J ;
Patel, M ;
Norozian, F ;
Wright, HV ;
Kashyap, MV ;
Barnstein, BO ;
Fischer-Stenger, K ;
Schwartz, LB ;
Kepley, CL ;
Ryan, JJ .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :5987-5993
[9]   Requirement for IL-13 independently of IL-4 in experimental asthma [J].
Grünig, G ;
Warnock, M ;
Wakil, AE ;
Venkayya, R ;
Brombacher, F ;
Rennick, DM ;
Sheppard, D ;
Mohrs, M ;
Donaldson, DD ;
Locksley, RM ;
Corry, DB .
SCIENCE, 1998, 282 (5397) :2261-2263
[10]   Evidence for a role of mast cells in the evolution to congestive heart failure [J].
Hara, M ;
Ono, K ;
Hwang, MW ;
Iwasaki, A ;
Okada, M ;
Nakatani, K ;
Sasayama, S ;
Matsumori, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (03) :375-381